{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:37:20Z","timestamp":1788482240485,"version":"build-2803163510"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,11,6]],"date-time":"2019-11-06T00:00:00Z","timestamp":1572998400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,11,6]],"date-time":"2019-11-06T00:00:00Z","timestamp":1572998400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infection"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1007\/s15010-019-01373-8","type":"journal-article","created":{"date-parts":[[2019,11,6]],"date-time":"2019-11-06T05:03:31Z","timestamp":1573016611000},"page":"37-42","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Considerations on nosology for HIV-associated neurocognitive disorders: it is time to update?"],"prefix":"10.1007","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7582-9142","authenticated-orcid":false,"given":"Nicoletta","family":"Ciccarelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,6]]},"reference":[{"key":"1373_CR1","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1080\/13550280902769756","volume":"15","author":"A Gongvatana","year":"2009","unstructured":"Gongvatana A, Schweinsburg BC, Taylor MJ, Theilmann RJ, Letendre SL, Alhassoon OM, et al. White matter tract injury and cognitive impairment in human immunodeficiency virus-infected individuals. J Neurovirol. 2009;15:187\u201395.","journal-title":"J Neurovirol"},{"key":"1373_CR2","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1097\/WNR.0b013e328311d374","volume":"19","author":"AD Klunder","year":"2008","unstructured":"Klunder AD, Chiang MC, Dutton RA, Lee SE, Toga AW, Lopez OL, et al. Mapping cerebellar degeneration in HIV\/AIDS. Neuroreport. 2008;19:1655\u20139.","journal-title":"Neuroreport"},{"key":"1373_CR3","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1212\/WNL.41.9.1355","volume":"41","author":"RS Janssen","year":"1991","unstructured":"Janssen RS, Cornblath DR, Epstein LG, Foa RP, McArthur JC, Price RW, et al. Nomenclature and research case definitions for neurological manifestations of human immunodeficiency virus type-1 (HIV-1) infection. Report of a Working Group of the American Academy of Neurology AIDS Task Force. Neurology. 1991;41:778\u201385.","journal-title":"Neurology"},{"key":"1373_CR4","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1002\/ana.410190602","volume":"19","author":"BA Navia","year":"1986","unstructured":"Navia BA, Jordan BD, Price RW. The AIDS dementia complex: I. Clinical features. Ann Neurol J. 1986;19:517\u201324.","journal-title":"Ann Neurol J"},{"key":"1373_CR5","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1212\/01.WNL.0000287431.88658.8b","volume":"69","author":"A Antinori","year":"2007","unstructured":"Antinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, Cherner M, et al. Updated research nosology for HIV-associated neurocognitive disorders. Neurology. 2007;69:1789\u201399.","journal-title":"Neurology"},{"key":"1373_CR6","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/1741-7015-9-138","volume":"9","author":"C Torti","year":"2011","unstructured":"Torti C, Foc\u00e0 E, Cesana BM, Lescure FX. Asymptomatic neurocognitive disorders in patients infected by HIV: fact or fiction? BMC Med. 2011;9:138.","journal-title":"BMC Med"},{"key":"1373_CR7","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1212\/WNL.56.2.257","volume":"56","author":"N Sacktor","year":"2001","unstructured":"Sacktor N, Lyles RH, Skolasky R, Kleeberger C, Selnes OA, Miller EN, et al. HIV-associated neurologic disease incidence changes: multicenter AIDS Cohort Study, 1990\u20131998. Neurology. 2001;56:257\u201360.","journal-title":"Neurology"},{"key":"1373_CR8","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.jneuroim.2004.08.042","volume":"157","author":"JC Mc Arthur","year":"2004","unstructured":"Mc Arthur JC. HIV Dementia: an evolving disease. J Neuroimmunol. 2004;157:3\u201310.","journal-title":"J Neuroimmunol"},{"key":"1373_CR9","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1212\/WNL.0b013e318200d727","volume":"75","author":"RK Heaton","year":"2010","unstructured":"Heaton RK, Clifford DB, Franklin DR Jr, Woods SP, Ake C, Vaida F, et al. HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology. 2010;75:2087\u201396.","journal-title":"Neurology"},{"key":"1373_CR10","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1097\/QAD.0b013e3283354a7b","volume":"24","author":"S Simioni","year":"2010","unstructured":"Simioni S, Cavassini M, Annoni JM, Rimbault Abraham A, Bourquin I, et al. Cognitive dysfunction in HIV patients despite long-standing suppression of viremia. AIDS. 2010;24:1243\u201350. https:\/\/doi.org\/10.1097\/QAD.0b013e3283354a7b .","journal-title":"AIDS"},{"key":"1373_CR11","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s11481-008-9143-1","volume":"4","author":"BJ Brew","year":"2009","unstructured":"Brew BJ, Crowe SM, Landay A, Cysique LA, Guillemin G. Neurodegeneration and aging in the HAART era. J Neuroimmune Pharmacol. 2009;4:163\u201374.","journal-title":"J Neuroimmune Pharmacol"},{"key":"1373_CR12","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1146\/annurev-med-042909-09375","volume":"62","author":"SG Deeks","year":"2011","unstructured":"Deeks SG. HIV infection, inflammation, immunosenescence, and aging. Annu Rev Med. 2011;62:141\u201355. https:\/\/doi.org\/10.1146\/annurev-med-042909-09375 .","journal-title":"Annu Rev Med"},{"key":"1373_CR13","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1212\/01.WNL.0000134665.58343.8D","volume":"63","author":"V Valcour","year":"2004","unstructured":"Valcour V, Shikuma C, Shiramizu B, Watters M, Poff P, Selnes O, et al. Higher frequency of dementia in older HIV-1 individuals: the Hawaii aging with HIV-1 cohort. Neurology. 2004;63:822\u20137.","journal-title":"Neurology"},{"key":"1373_CR14","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1007\/s11481-009-9152-8","volume":"4","author":"CL Achim","year":"2009","unstructured":"Achim CL, Adame A, Dumaop W, Everall IP, Masliah E. Increased accumulation of intraneuronal amyloid beta in HIV-infected patients. J Neuroimmune Pharmacol. 2009;4:190\u20139.","journal-title":"J Neuroimmune Pharmacol"},{"key":"1373_CR15","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.1111\/j.1532-5415.2012.04213.x","volume":"60","author":"N Ciccarelli","year":"2012","unstructured":"Ciccarelli N, Fabbiani M, Baldonero E, Fanti I, Cauda R, Di Giambenedetto S, et al. Effect of aging and human immunodeficiency virus infection on cognitive abilities. J Am Geriatr Soc. 2012;60:2048\u201355. https:\/\/doi.org\/10.1111\/j.1532-5415.2012.04213.x .","journal-title":"J Am Geriatr Soc"},{"key":"1373_CR16","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1080\/23279095.2016.1189424","volume":"24","author":"N Ciccarelli","year":"2017","unstructured":"Ciccarelli N, Limiti S, Fabbiani M, Baldonero E, Milanini B, Lamonica S, et al. Verbal list learning and memory profiles in HIV-infected adults, Alzheimer\u2019s disease, and Parkinson\u2019s disease: an evaluation of the \u201ccortical hypothesis\u201d of NeuroAIDS. Appl Neuropsychol Adult. 2017;24:410\u20139. https:\/\/doi.org\/10.1080\/23279095.2016.1189424 .","journal-title":"Appl Neuropsychol Adult"},{"key":"1373_CR17","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1176\/appi.neuropsych.23.1.83","volume":"23","author":"LA Cysique","year":"2011","unstructured":"Cysique LA, Maruff P, Bain MP, Wright E, Brew BJ. HIV and age do not substantially interact in HIVassociated neurocognitive impairment. J Neuropsychiatry. 2011;23:83\u20139. https:\/\/doi.org\/10.1176\/appi.neuropsych.23.1.83 .","journal-title":"J Neuropsychiatry"},{"key":"1373_CR18","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1007\/s10461-010-9815-8","volume":"6","author":"JC Scott","year":"2011","unstructured":"Scott JC, Woods SP, Carey CL, Weber E, Bondi MW, Grant I. Neurocognitive consequences of HIV infection in older adults: an evaluation of the \u201ccortical\u201d hypothesis. AIDS Behav. 2011;6:1187\u201396. https:\/\/doi.org\/10.1007\/s10461-010-9815-8 .","journal-title":"AIDS Behav"},{"key":"1373_CR19","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1017\/S1355617710001438","volume":"17","author":"V Valcour","year":"2011","unstructured":"Valcour V, Paul R, Neuhaus J, Shikuma C. The effects of age and HIV on neuropsychological performance. J Int Neuropsychol Soc. 2011;17:190\u20135. https:\/\/doi.org\/10.1017\/S1355617710001438 .","journal-title":"J Int Neuropsychol Soc"},{"key":"1373_CR20","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1017\/S1355617702813248","volume":"8","author":"Y Stern","year":"2002","unstructured":"Stern Y. What is cognitive reserve? Theory and research application of the reserve concept. J Int Neuropsychol Soc. 2002;8:448\u201360.","journal-title":"J Int Neuropsychol Soc"},{"key":"1373_CR21","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/s13365-016-0426-7","volume":"22","author":"B Milanini","year":"2016","unstructured":"Milanini B, Ciccarelli N, Fabbiani M, Limiti S, Grima P, Rossetti B, et al. Cognitive reserve and neuropsychological functioning in older HIV-infected people. J Neurovirol. 2016;22:575\u201383.","journal-title":"J Neurovirol"},{"key":"1373_CR22","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1007\/s10461-012-0229-7","volume":"16","author":"EE Morgan","year":"2012","unstructured":"Morgan EE, Woods SP, Smith C, Weber E, Scott JC, Grant I. Lower cognitive reserve among individuals with syndromic HIV-associated neurocognitive disorders (HAND). AIDS Behav. 2012;16:2279\u201385.","journal-title":"AIDS Behav"},{"key":"1373_CR23","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s10865-009-9212-9","volume":"32","author":"T Lovejoy","year":"2009","unstructured":"Lovejoy T, Suhr JA. The relationship between neuropsychological functioning and HAART adherence in HIV-positive adults: a systematic review. J Behav Med. 2009;32:389\u2013405. https:\/\/doi.org\/10.1007\/s10865-009-9212-9 .","journal-title":"J Behav Med"},{"key":"1373_CR24","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1212\/WNL.0b013e31821670fb","volume":"76","author":"N Ciccarelli","year":"2011","unstructured":"Ciccarelli N, Fabbiani M, Di Giambenedetto S, Fanti I, Baldonero E, Bracciale L, et al. Efavirenz associated with cognitive disorders in otherwise asymptomatic HIV-infected patients. Neurology. 2011;76:1403\u20139. https:\/\/doi.org\/10.1212\/WNL.0b013e31821670fb .","journal-title":"Neurology"},{"key":"1373_CR25","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1097\/QAD.0000000000000538","volume":"29","author":"J Underwood","year":"2015","unstructured":"Underwood J, Robertson KR, Winston A. Could antiretroviral neurotoxicity play a role in the pathogenesis of cognitive impairment in treated HIV disease? AIDS. 2015;29:253\u201361.","journal-title":"AIDS"},{"key":"1373_CR26","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1001\/archneurol.2007.31","volume":"65","author":"S Letendre","year":"2008","unstructured":"Letendre S, Marquie-Beck J, Capparelli E, Best B, Clifford D, Collier AC, et al. Validation of the CNS penetration-effectiveness rank for quantifying antiretroviral penetration into the central nervous system. Arch Neurol. 2008;65:65\u201370.","journal-title":"Arch Neurol"},{"key":"1373_CR27","first-page":"137","volume":"19","author":"S Letendre","year":"2011","unstructured":"Letendre S. Central nervous system complications in HIV disease: HIV-associated neurocognitive disorder. Top Antivir Med. 2011;19:137.","journal-title":"Top Antivir Med"},{"key":"1373_CR28","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/1471-2377-11-148","volume":"11","author":"LA Cysique","year":"2011","unstructured":"Cysique LA, Waters EK, Brew BJ. Central nervous system antiretroviral efficacy in HIV infection: a qualitative and quantitative review and implications for future research. BMC Neurol. 2011;11:148. https:\/\/doi.org\/10.1186\/1471-2377-11-148 .","journal-title":"BMC Neurol"},{"key":"1373_CR29","doi-asserted-by":"publisher","first-page":"153","DOI":"10.3851\/IMP2560","volume":"18","author":"N Ciccarelli","year":"2013","unstructured":"Ciccarelli N, Fabbiani M, Colafigli M, Trecarichi EM, Silveri MC, Cauda R, et al. Revised central nervous system neuropenetration-effectiveness score is associated with cognitive disorders in HIV-infected patients with controlled plasma viraemia. Antivir Ther. 2013;18:153\u201360. https:\/\/doi.org\/10.3851\/IMP2560 .","journal-title":"Antivir Ther"},{"key":"1373_CR30","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1093\/cid\/cit921","volume":"58","author":"RJ Ellis","year":"2014","unstructured":"Ellis RJ, Letendre S, Vaida F, Haubrich R, Heaton RK, Sacktor N, et al. Randomized trial of central nervous system-targeted antiretrovirals for HIV-associated neurocognitive disorder. Clin Infect Dis. 2014;58:1015\u201322. https:\/\/doi.org\/10.1093\/cid\/cit921 .","journal-title":"Clin Infect Dis"},{"key":"1373_CR31","doi-asserted-by":"publisher","first-page":"441","DOI":"10.3851\/IMP2926","volume":"20","author":"M Fabbiani","year":"2015","unstructured":"Fabbiani M, Grima P, Milanini B, Mondi A, Baldonero E, Ciccarelli N, et al. Antiretroviral neuropenetration scores better correlate with cognitive performance of HIV-infected patients after accounting for drug susceptibility. Antivir Ther. 2015;20:441\u20137. https:\/\/doi.org\/10.3851\/IMP2926 .","journal-title":"Antivir Ther"},{"key":"1373_CR32","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1086\/650538","volume":"50","author":"A Canestri","year":"2010","unstructured":"Canestri A, Lescure FX, Jaureguiberry S, Moulignier A, Amiel C, Marcelin AG, et al. Discordance between cerebral spinal fluid and plasma HIV replication in patients with neurological symptoms who are receiving suppressive antiretroviral therapy. Clin Infect Dis. 2010;50:773\u20138.","journal-title":"Clin Infect Dis"},{"key":"1373_CR33","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1097\/QAD.0b013e328355e6b2","volume":"26","author":"MJ Peluso","year":"2012","unstructured":"Peluso MJ, Ferretti F, Peterson J, Lee E, Fuchs D, Boschini A, et al. Cerebrospinal fluid HIV escape associated with progressive neurologic dysfunction in patients on antiretroviral therapy with well controlled plasma viral load. AIDS. 2012;26:1765\u201374. https:\/\/doi.org\/10.1097\/QAD.0b013e328355e6b2 .","journal-title":"AIDS"},{"key":"1373_CR34","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1086\/657342","volume":"202","author":"A Ed\u00e9n","year":"2010","unstructured":"Ed\u00e9n A, Fuchs D, Hagberg L, Nilsson S, Spudich S, Svennerholm B, et al. HIV-1 viral escape in cerebrospinal fluid of subjects on suppressive antiretroviral treatment. J Infect Dis. 2010;202:1819\u201325.","journal-title":"J Infect Dis"},{"key":"1373_CR35","first-page":"18189","volume":"15","author":"IP Valero","year":"2012","unstructured":"Valero IP, Letendre S, Ellis R, Deutsch R, Franklin D, Clifford D, et al. Prevalence and risk factors for HIV CSF Viral Escape: results from the CHARTER and HNRP cohorts. J Int AIDS Soc. 2012;15:18189.","journal-title":"J Int AIDS Soc"},{"key":"1373_CR36","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1080\/09540260701878082","volume":"20","author":"BJ Brew","year":"2008","unstructured":"Brew BJ, Letendre SL. Biomarkers of HIV related central nervous system disease. Int Rev Psychiatry. 2008;20:73\u201388. https:\/\/doi.org\/10.1080\/09540260701878082 (Review).","journal-title":"Int Rev Psychiatry"},{"key":"1373_CR37","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1016\/S1474-4422(14)70137-1","volume":"13","author":"S Nightingale","year":"2014","unstructured":"Nightingale S, Winston A, Letendre S, Michael BD, McArthur JC, Khoo S, et al. Controversies in HIV associated neurocognitive disorders. Lancet Neurol. 2014;13:1139\u201351.","journal-title":"Lancet Neurol"},{"key":"1373_CR38","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1097\/QAD.0b013e32834a40cd","volume":"25","author":"RJ Ellis","year":"2011","unstructured":"Ellis RJ, Badiee J, Vaida F, Letendre S, Heaton RK, Clifford D, et al. CD4 nadir is a predictor of HIV neurocognitive impairment in the era of combination antiretroviral therapy. AIDS. 2011;25:1747\u201351.","journal-title":"AIDS"},{"key":"1373_CR39","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1097\/QAD.0b013e32833a3946","volume":"24","author":"AI Van Sighem","year":"2010","unstructured":"Van Sighem AI, Gras LA, Reiss P, Brinkman K, De Wolf F. Life expectancy of recently diagnosed asymptomatic HIV-infected patients approaches that of uninfected individuals. AIDS. 2010;24:1527\u201335.","journal-title":"AIDS"},{"key":"1373_CR40","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1002\/ana.22053","volume":"67","author":"JC McArthur","year":"2010","unstructured":"McArthur JC, Steiner J, Sacktor N, Nath A. Human immunodeficiency virus-associated neurocognitive disorders: mind the gap. Ann Neurol. 2010;67:699\u2013714.","journal-title":"Ann Neurol"},{"key":"1373_CR41","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1097\/01.aids.0000432467.54003.f7","volume":"28","author":"LJ Garvey","year":"2014","unstructured":"Garvey LJ, Pavese N, Politis M, Ramlackhansingh A, Brooks DJ, Taylor-Robinson SD, et al. Increased microglia activation in neurologically asymptomatic HIV-infected patients receiving effective ART. AIDS. 2014;28:67\u201372.","journal-title":"AIDS"},{"key":"1373_CR42","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1007\/s13365-013-0213-7","volume":"19","author":"BK Nakamoto","year":"2013","unstructured":"Nakamoto BK, Shikuma CM, Ogata-Arakaki D, Umaki T, Neuwelt EA, Shiramizu BT, et al. Feasibility and potential role of ferumoxytol-enhanced neuroimaging in HIV-associated neurocognitive disorder. J Neurovirol. 2013;19:601\u20135.","journal-title":"J Neurovirol"},{"key":"1373_CR43","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1097\/COH.0000000000000104","volume":"9","author":"J Hellmuth","year":"2014","unstructured":"Hellmuth J, Milanini B, Valcour V. Interactions between ageing and NeuroAIDS. Curr Opin HIVAIDS. 2014;9:527\u201332. https:\/\/doi.org\/10.1097\/COH.0000000000000104 .","journal-title":"Curr Opin HIVAIDS"},{"key":"1373_CR44","doi-asserted-by":"publisher","first-page":"e116081","DOI":"10.1371\/journal.pone.0116081","volume":"9","author":"J Peterson","year":"2014","unstructured":"Peterson J, Gisslen M, Zetterberg H, Fuchs D, Shacklett BL, Hagberg L, et al. Cerebrospinal fluid (CSF) neuronal biomarkers across the spectrum of HIV infection: hierarchy of injury and detection. PLoS One. 2014;9:e116081.","journal-title":"PLoS One"},{"key":"1373_CR45","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1007\/s00415-012-6688-y","volume":"260","author":"JJ Krut","year":"2013","unstructured":"Krut JJ, Zetterberg H, Blennow K, Cinque P, Hagberg L, Price RW, et al. Cerebrospinal fluid Alzheimer\u2019s biomarker profiles in CNS infections. J Neurol. 2013;260:620\u20136. https:\/\/doi.org\/10.1007\/s00415-012-6688-y .","journal-title":"J Neurol"},{"key":"1373_CR46","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.ebiom.2015.11.036","volume":"3","author":"M Gissl\u00e9n","year":"2015","unstructured":"Gissl\u00e9n M, Price RW, Andreasson U, Norgren N, Nilsson S, Hagberg L, et al. Plasma concentration of the neurofilament light protein (NFL) is a biomarker of CNS injury in HIV infection: a cross-sectional study. EBioMedicine. 2015;3:135\u201340. https:\/\/doi.org\/10.1016\/j.ebiom.2015.11.036 .","journal-title":"EBioMedicine"},{"key":"1373_CR47","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s11904-017-0361-0","volume":"14","author":"B Milanini","year":"2017","unstructured":"Milanini B, Valcour V. Differentiating HIV-associated neurocognitive disorders from Alzheimer\u2019s disease: an emerging issue in geriatric NeuroHIV. Curr HIV AIDS Rep. 2017;14:123\u201332. https:\/\/doi.org\/10.1007\/s11904-017-0361-0 (Review).","journal-title":"Curr HIV AIDS Rep"},{"key":"1373_CR48","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1093\/aje\/kwu098","volume":"180","author":"ER Hammond","year":"2014","unstructured":"Hammond ER, Crum RM, Treisman GJ, Mehta SH, Marra CM, Clifford DB, et al. The cerebrospinal fluid HIV risk score for assessing central nervous system activity in persons with HIV. Am J Epidemiol. 2014;180:297\u2013307. https:\/\/doi.org\/10.1093\/aje\/kwu098 .","journal-title":"Am J Epidemiol"},{"key":"1373_CR49","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1097\/QAD.0000000000000243","volume":"28","author":"MT May","year":"2014","unstructured":"May MT, Gompels M, Delpech V, et al. UK collaborative HIV cohort (UK CHIC)-study impact on life expectancy of HIV-1 positive individuals of CD4\u2009+\u2009cell count and viral load response to antiretroviral therapy. AIDS. 2014;28:1193\u2013202.","journal-title":"AIDS"},{"key":"1373_CR50","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1310\/hct1206-333","volume":"12","author":"L Garvey","year":"2011","unstructured":"Garvey L, Surendrakumar V, Winston A. Low rates of neurocognitive impairment are observed in neuro-asymptomatic HIV-infected subjects on effective antiretroviral therapy. HIV Clin Trials. 2011;12:333\u20138. https:\/\/doi.org\/10.1310\/hct1206-333 .","journal-title":"HIV Clin Trials"},{"key":"1373_CR51","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1212\/WNL.0000000000000492","volume":"82","author":"I Grant","year":"2014","unstructured":"Grant I, Franklin DR Jr, Deutsch R, Woods SP, Vaida F, Ellis RJ, et al. Asymptomatic HIV-associated neurocognitive impairment increases risk for symptomatic decline. Neurology. 2014;82:2055\u201362. https:\/\/doi.org\/10.1212\/WNL.0000000000000492 .","journal-title":"Neurology"},{"key":"1373_CR52","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1186\/1471-2334-11-356","volume":"11","author":"M Gissl\u00e9n","year":"2011","unstructured":"Gissl\u00e9n M, Price RW, Nilsson S. The definition of HIV-associated neurocognitive disorders: are we overestimating the real prevalence? BMC Infect Dis. 2011;11:356.","journal-title":"BMC Infect Dis"},{"key":"1373_CR53","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1007\/s15010-013-0503-2","volume":"41","author":"N Ciccarelli","year":"2013","unstructured":"Ciccarelli N, Fabbiani M, Grima P, Falasca K, Tana M, Baldonero E, et al. Comparison of cognitive performance in HIV or HCV mono-infected and HIV-HCV co-infected patients. Infection. 2013;41:1103\u20139. https:\/\/doi.org\/10.1007\/s15010-013-0503-2 .","journal-title":"Infection"},{"key":"1373_CR54","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.jns.2011.08.025","volume":"312","author":"P Vivithanaporn","year":"2012","unstructured":"Vivithanaporn P, Nelles K, DeBlock L, Newman SC, Gill MJ. Power C Hepatitis C virus co-infection increases neurocognitive impairment severity and risk of death in treated HIV\/AIDS. J Neurol Sci. 2012;312:45\u201351.","journal-title":"J Neurol Sci"},{"key":"1373_CR55","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1212\/WNL.0b013e3181f11bd8","volume":"75","author":"EJ Wright","year":"2010","unstructured":"Wright EJ, Grund B, Robertson K, Brew BJ, Roediger M, Bain MP, et al. Cardiovascular risk factors associated with lower baseline cognitive performance in HIV-positive persons. Neurology. 2010;75:864\u201373.","journal-title":"Neurology"},{"key":"1373_CR56","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1176\/appi.psy.45.5.394","volume":"45","author":"A Ammassari","year":"2004","unstructured":"Ammassari A, Antinori A, Aloisi MS, Trotta MP, Murri R, Bartoli L, et al. Depressive symptoms, neurocognitive impairment, and adherence to highly active antiretroviral therapy among HIV-infected persons. Psychosomatics. 2004;45:394\u2013402.","journal-title":"Psychosomatics"},{"key":"1373_CR57","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1111\/j.1468-1293.2012.01044.x","volume":"14","author":"M Fabbiani","year":"2013","unstructured":"Fabbiani M, Ciccarelli N, Tana M, Farina S, Baldonero E, Di Cristo V, et al. Cardiovascular risk factors and carotid intima-media thickness are associated with lower cognitive performance in HIV-infected patients. HIV Med. 2013;14:136\u201344. https:\/\/doi.org\/10.1111\/j.1468-1293.2012.01044.x .","journal-title":"HIV Med"},{"key":"1373_CR58","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1097\/QAI.0b013e318278f3fa","volume":"62","author":"KM Akg\u00fcn","year":"2013","unstructured":"Akg\u00fcn KM, Gordon K, Pisani M, Fried T, McGinnis KA, Tate JP, et al. Risk factors for hospitalization and medical intensive care unit (MICU) admission among HIV-infected Veterans. J Acquir Immune Def Syndr. 2013;62:52\u20139.","journal-title":"J Acquir Immune Def Syndr"},{"key":"1373_CR59","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1093\/cid\/ciw328","volume":"63","author":"MJ Marquine","year":"2016","unstructured":"Marquine MJ, Montoya JL, Umlauf A, Fazeli PL, Gouaux B, Heaton RK, et al. The veterans aging cohort study (VACS) index and neurocognitive change: a longitudinal study. Clin Infect Dis. 2016;63:694\u2013702. https:\/\/doi.org\/10.1093\/cid\/ciw328 .","journal-title":"Clin Infect Dis"},{"key":"1373_CR60","doi-asserted-by":"publisher","first-page":"996","DOI":"10.2174\/1570159X15666170313122937","volume":"15","author":"M Sochocka","year":"2017","unstructured":"Sochocka M, Zwoli\u0144ska K, Leszek J. The infectious etiology of Alzheimer\u2019s disease. Curr Neuropharmacol. 2017;15:996\u20131009. https:\/\/doi.org\/10.2174\/1570159X15666170313122937 (Review).","journal-title":"Curr Neuropharmacol"},{"key":"1373_CR61","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.4103\/1673-5374.253508","volume":"14","author":"MA Romeo","year":"2019","unstructured":"Romeo MA, Faggioni A, Cirone M. Could autophagy dysregulation link neurotropic viruses to Alzheimer\u2019s disease? Neural Regen Res. 2019;14:1503\u20136.","journal-title":"Neural Regen Res"},{"key":"1373_CR62","doi-asserted-by":"publisher","first-page":"711","DOI":"10.3389\/fonc.2019.00711","volume":"9","author":"Del Valle","year":"2019","unstructured":"Valle Del, Pi\u00f1a-Oviedo S. Human polyomavirus JCPyV and its role in progressive multifocal leukencephalopathy and oncogenesis. Front Oncol. 2019;9:711.","journal-title":"Front Oncol"},{"key":"1373_CR63","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s12981-018-0204-0","volume":"15","author":"PG Clay","year":"2018","unstructured":"Clay PG, Yuet WC, Moecklinghoff CH, Duchesne I, Tronczy\u0144ski KL, Shah S, Shao D. A meta-analysis comparing 48-week treatment outcomes of single and multi-tablet antiretroviral regimens for the treatment of people living with HIV. AIDS Res Ther. 2018;15:17. https:\/\/doi.org\/10.1186\/s12981-018-0204-0 .","journal-title":"AIDS Res Ther"},{"key":"1373_CR64","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1089\/aid.2018.0279","volume":"35","author":"I Portilla","year":"2019","unstructured":"Portilla I, Reus S, Le\u00f3n R, van-der Hofstadt C, S\u00e1nchez J, L\u00f3pez N, et al. Neurocognitive impairment in well-controlled HIV-infected patients: a cross-sectional study. AIDS Res Hum Retrovir. 2019;35:634\u201341. https:\/\/doi.org\/10.1089\/aid.2018.0279 .","journal-title":"AIDS Res Hum Retrovir"},{"key":"1373_CR65","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1007\/s11065-009-9096-z","volume":"19","author":"K Robertson","year":"2009","unstructured":"Robertson K, Liner J, Heaton R. Neuropsychological assessment of HIV-infected populations in international settings. Neuropsychol Rev. 2009;19:232\u201349. https:\/\/doi.org\/10.1007\/s11065-009-9096-z .","journal-title":"Neuropsychol Rev"},{"key":"1373_CR66","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1177\/1533317518791401","volume":"33","author":"Jongsiriyanyong & Limpawattana","year":"2018","unstructured":"Jongsiriyanyong & Limpawattana. Mild cognitive impairment in clinical practice: a review article. Am J Alzheimers Dis Other Demen. 2018;33:500\u20137. https:\/\/doi.org\/10.1177\/1533317518791401 .","journal-title":"Am J Alzheimers Dis Other Demen"},{"key":"1373_CR67","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1001\/archneur.56.3.303","volume":"56","author":"RC Petersen","year":"1999","unstructured":"Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol. 1999;56:303\u20138.","journal-title":"Arch Neurol"},{"key":"1373_CR68","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1080\/01688639708403761","volume":"19","author":"E Capitani","year":"1997","unstructured":"Capitani E, Laiacona M. Composite neuropsychological batteries and demographic correction: standardization based on equivalent scores, with a review of published data: the Italian group for the neuropsychological study of ageing. J Clin Exp Neuropsychol. 1997;19:795\u2013809.","journal-title":"J Clin Exp Neuropsychol"},{"key":"1373_CR69","doi-asserted-by":"publisher","DOI":"10.1080\/13854046.2012.694479","author":"K Blackstone","year":"2012","unstructured":"Blackstone K, Moore DJ, Franklin DR Jr, Clifford DB, Collier AC, Marra CM, For the CHARTER group, et al. Defining neurocognitive impairment in HIV: deficit scores versus clinical ratings. K. Clin Neuropsychol. 2012. https:\/\/doi.org\/10.1080\/13854046.2012.694479 .","journal-title":"K. Clin Neuropsychol"}],"container-title":["Infection"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-019-01373-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s15010-019-01373-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-019-01373-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T05:55:27Z","timestamp":1721973327000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s15010-019-01373-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,6]]},"references-count":69,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["1373"],"URL":"https:\/\/doi.org\/10.1007\/s15010-019-01373-8","relation":{},"ISSN":["0300-8126","1439-0973"],"issn-type":[{"value":"0300-8126","type":"print"},{"value":"1439-0973","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,6]]},"assertion":[{"value":"22 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The author declares that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}